Cadre Holdings, Inc. Liquidation Value

CDRE Medical Devices

Cash & Equivalents

$41.27M
As of 2026-03-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $41.27M
Total Obligations: -$528.82M
$-487.54M
Per share: $-11.39
Period: 2026-03-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $41.27M
AR: $111.29M
Total Obligations: -$528.82M
$-376.25M
Per share: $-8.79
Period: 2026-03-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $41.27M
AR: $111.29M
Inventory: $130.99M
Total Obligations: -$528.82M
$-245.26M
Per share: $-5.73
Period: 2026-03-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-487.54M$-11.39
Liquid Liquidation Value$-376.25M$-8.79
Operating Liquidation Value$-245.26M$-5.73

Key Components (as of 2026-03-31)

Data as of 2026-03-31 from 10-Q filed 2026-05-11. View on SEC EDGAR →

Cash & Equivalents$41.27M
Accounts Receivable$111.29M
Inventory$130.99M
Current Liabilities$141.17M
Long-term Debt (?)$349.57M
Op. Lease Liability (?)$14.97M
Finance Lease (?)N/A
Shares Outstanding42.8M

Explore all 151 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$41.27M$111.29M$130.99M$39.90M$141.17M$349.57M$14.97MN/A
2025-12-31$122.90M$110.61M$100.26M$22.32M$104.50M$290.99M$15.04M$2.49M
2025-09-30$150.88M$99.43M$112.20M$27.00M$106.04M$294.97M$16.03M$2.51M
2025-06-30$137.47M$108.13M$109.60M$32.00M$106.07M$298.88M$15.64M$2.60M

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-05-11 View
2025-12-31 10-K 2026-03-10 View
2025-09-30 10-Q 2025-11-04 View
2025-06-30 10-Q 2025-08-05 View
2025-03-31 10-Q 2025-05-06 View
2024-12-31 10-K 2025-03-11 View
2024-09-30 10-Q 2024-11-06 View
2024-06-30 10-Q 2024-08-09 View

AI Insights

AI Insight·Generated 2026-05-12

Cadre Holdings (CDRE) presents a deeply negative liquidation posture as of March 31, 2026, consistent with its acquisition-heavy capital structure. MFFAIS pre-computed liquidation values confirm this: cash liquidation value of approximately -$290M, liquid liquidation value of approximately -$180M, and operating liquidation value of approximately -$79M. The gap between the three metrics reflects the standard haircut progression — cash and near-liquid assets recover poorly against a face-value liability stack dominated by term debt.

The primary driver of the deterioration relative to the prior filing (10-K for year ended December 31, 2025) is the January 2026 acquisition of TYR Tactical, LLC for $185.2 million, funded primarily through the 2024 Credit Agreement (including a $62.5M draw on the revolving facility). Outstanding debt, net of discounts and issuance costs, rose from $307.3M at December 31, 2025 to $365.8M at March 31, 2026 — an increase of approximately $58.5M in one quarter. Gross contractual debt obligations per the contractual obligations table stand at $367.6M, with $322.9M maturing in the 3-5 year bucket (December 2029 maturity under the 2024 Credit Agreement). The TYR acquisition also generated $2.6M of inventory step-up amortization in Q1 2026 (versus zero in Q1 2025), compressing reported gross margin, though this is a transient income-statement effect and does not directly affect liquidation asset recovery.

On the asset side, under a liquidation lens, the balance sheet is dominated by goodwill and intangible assets — both assigned zero recovery. The filing does not separately disclose balance sheet totals by line item in the XBRL tag context provided, but the MD&A confirms cash and equivalents of $41.3M at March 31, 2026, down from $125.3M at the start of Q1 2026 after the TYR acquisition cash outflow of $153.6M was partially offset by $62.5M in revolving credit draws and $22.5M in operating cash flow. Inventory increased during the quarter (operating cash flow discussion notes a $10.5M inventory build), which at a 60% recovery rate contributes positively but is offset by the enlarged debt stack at face value.

Operating lease liabilities increased, with $2.7M of new ROU assets obtained in exchange for operating lease obligations in Q1 2026 versus $1.9M in Q1 2025 — a modest but directionally negative shift for the liability stack.

A subsequent event (April 2026 Alien Gear acquisition for $10.3M cash via bankruptcy auction) further depletes cash post-period. The leverage covenant step-down from 4.00x to 3.50x net leverage takes effect after Q1 2026; the filing discloses a temporary covenant relief provision available for material acquisitions (up to 0.50x add-back for four quarters), which the TYR acquisition likely triggered.

The TAG_CONTEXT list provided contains no XBRL tags, so no individual tags can be flagged in tag_insights. All balance sheet observations are drawn from narrative and MD&A disclosures in the filing body.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...